Opinion

New eligibility requirements for Medicaid threaten those who need coverage the most.

China’s State Council imposes new requirements to curb the abusive aspects of regulatory guidance documents.

The permissive drug approval process enabled by the 21st Century Cures Act may cause public health problems.

The Administration’s goal of “streamlining” infrastructure review is fundamentally misguided.

To improve the health care system, the values Americans have about health care must change.

Food regulators in the United States should adopt smarter front-of-package labeling to encourage healthier eating.

Given its importance in scientific development, human subjects research requires close regulatory attention.

The time has come for repealing Medicaid’s Institutions for Mental Diseases Exclusion rule.

The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.

A recent Supreme Court decision could allow courts to rely on dubious science.

Although “Medicare for all” has picked up political traction, how it will materialize remains unclear.

In its novel effort to bring independent agency regulations under White House oversight, the Trump Administration may have found a lasting legacy.